1.02 USD
↘ 0.03 (2.40%)AT CLOSE (03:59 PM EDT)
Biofrontera Inc. Common Stock
BFRINASDAQ • USD
1.06
↗ 0.05 (4.43%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
1.06
↗ 0.05 (4.43%)
Market: CLOSED
BFRI is currently priced at $1.02. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, BFRI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 2, 2026.
Open?$1.11
High?$1.12
Low?$1.00
Prev. Close?$1.04
Volume?334.8K
Avg. Volume?671.2K
VWAP?$1.04
Rel. Volume?0.50x
Bid / Ask
Bid?$1.01 × 100
Ask?$1.13 × 2.9K
Spread?$0.12
Midpoint?$1.07
Valuation & Ratios
Market Cap?15.1M
Shares Out?14.9M
Float?11.3M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?2.54
EPS?-$0.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Employees
94
Market Cap
15.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-29
Address
120 PRESIDENTIAL WAY,
WOBURN, MA 01801
Phone: 781-245-1325
WOBURN, MA 01801
Phone: 781-245-1325
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?0
Momentum?50
Short Sent.?51
Piotroski F-Score?5/9Mixed
Altman Z-Score?-6.14Distress
Confidence?54%Low
Short InterestLow
Short % of Float?4.11%Low
Short Interest?464.8K
Days to Cover?1.0
Free Float11.3M
Avg Daily Volume1.0M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.18Adequate
Quick Ratio?1.08Adequate
Cash Ratio?0.44Low
Debt/Equity?0.78Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.54CHEAP▾
Peers100
S&P64
P/S?0.33CHEAP▾
Peers100
S&P97
P/FCF?N/A▾
EV/EBITDA?-2.4CHEAP▾
S&P97
EV/Sales?0.33CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-106.9%WEAK▾
S&P3
ROA?-26.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-7930000
Enterprise Value?$15.1M
Fundamentals ratios updated end of day